Sauchelli S, Brunstrom JM. Virtual reality exergaming improves affect during physical activity and reduces subsequent food consumption in inactive adults. Appetite. 2022 Aug 1;175:106058. doi: 10.1016/j.appet.2022.106058
Rivero-Ferrer E, Olesen M, Plana E, Aguado J, Saigi-Morgui N, Rubino A, Daoud SZ, Lei A, Perez-Gutthann S, Schink S, Kristiansen NS, Hallas J, Pottegard A, Rebordosa C. Characteristics of new users of aclidinium bromide, aclidinium/formoterol, and other COPD medications in the United Kingdom, Denmark, and Germany. Clin Drug Invest. 2022 Apr;42(4):319-31. doi: 10.1007/s40261-022-01120-2
Cox JS, Hinton EC, Sauchelli S, Hamilton-Shield JP, Lawrence NS, Brunstrom JM. When do children learn how to select a portion size? Appetite. 2021 Sep 1;164:105247. doi: 10.1016/j.appet.2021.105247
Sauchelli S, Whitmarsh A, Hamilton-Shield J, Rogers PJ, Brunstrom JM. Adjusting the 'gravitostat': piloting the increase in torso loading to reduce adiposity. Appetite. 2021 Feb 1;157:104944. doi: 10.1016/j.appet.2020.104944
Requena G, Ma L, Sturmer T, Layton JB, DiBello J. Association between an acute, drug-induced decrease in high-density lipoprotein cholesterol levels and risk of cardiovascular events. Clin Drug Invest. 2020 Aug;40:747-54. doi: 10.1007/s40261-020-00935-1
Magrey M, Bozyczko M, Wolin D, Mordin M, McLeod L, Davenport E, Chirila C, Hur P. Evaluation of the feasibility of a web-based survey to assess patient-reported symptom improvement and treatment satisfaction among patients with psoriatic arthritis receiving Secukinumab. Clin Drug Invest. 2019 Dec;39(12):1205-12. doi: 10.1007/s40261-019-00856-8
Sauchelli S, Clark E, Shield J, Brunstrom J, Rogers P. Food preferences in children with insulin-induced hypoglycaemia: the development of a food preference task. Poster presented at the 42nd Meeting of the British Feeding and Drinking Group; April 2018. [abstract] Appetite. 2018 Nov 1; 130:315. doi: 10.1016/j.appet.2018.05.233
McKenna SP, Doward LC, Davey KM. The development and psychometric properties of the MSQOL: a migraine-specific quality-of-life instrument. Clin Drug Invest. 1998;15(5):413-23.